Download PDF
Z Geburtshilfe Neonatol 2023; 227(06): 466-473
DOI: 10.1055/a-2096-6230
Kasuistik

Akute Schwangerschaftsfettleber – Fallserie einer seltenen Schwangerschaftskomplikation

Acute Fatty Liver of Pregnancy – Case Series
Martina Brügge
1   Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Schleswig-Holstein Campus Kiel, Kiel, Germany
,
Ulrich Pecks
1   Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Schleswig-Holstein Campus Kiel, Kiel, Germany
,
Antonella Iannaccone
2   Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Essen, Essen, Germany
,
Monika Palz-Fleige
3   Klinik für Gynäkologie und Geburtshilfe, St.-Johannes-Hospital Dortmund, Dortmund, Germany
,
Holger Stepan
4   Geburtsmedizin, Universitätsfrauenklinik Leipzig, Leipzig, Germany
,
Anne Tauscher
5   Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Leipzig, Leipzig, Germany
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Zusammenfassung

Die akute Schwangerschaftsfettleber (acute fatty liver in pregnancy, AFLP) ist mit einer Prävalenz von 0,01–0,03% eine seltene, potentiell lebensbedrohliche Komplikation in der Schwangerschaft. Durch die meist unspezifischen Symptome lässt sie sich schwer von anderen, teils häufigeren, Schwangerschaftserkrankungen wie HELLP Syndrom, aHUS und TTP abgrenzen. Ihre Seltenheit führt dazu, dass sie durch in der Geburtshilfe tätige Personen als Differentialdiagnose oft nicht in Erwägung gezogen wird. Dabei ist gerade die frühzeitige Diagnosestellung und schnellstmögliche Entbindung als einzige kausale Therapie entscheidend zur Verhinderung schwerwiegender Komplikationen und mütterlicher Todesfälle. In nachfolgender Arbeit wird anhand von Fallbeschreibungen dreier Uniklinika die Pathophysiologie, Bedeutung, Diagnose und Therapie der akuten Schwangerschaftsfettleber für die klinische Routine hervorgehoben und auf mögliche Befunde, welche in der Diagnosefindung zielführend sind, hingewiesen. Hierbei spielt auch der angiogene Präeklampsie-Marker sFlt-1 eine Rolle und bietet neue Betrachtungsweisen pathophsiologischer Ansätze.

Abstract

With a prevalence of 0,01-0,03%, acute fatty liver in pregnancy (AFLP) is a rare and dangerous complication of pregnancy and is difficult to distinguish from other, sometimes more common, pregnancy diseases such as HELLP syndrome, aHUS and TTP because of its mostly non-specific symptoms. Due to its rarity, AFLP is often not obvious to the obstetrician as a possible differential diagnosis. Yet early diagnosis and the fastest possible delivery is the only causal therapy and is important for the mortality rate. In the present manuscript, the pathophysiology, diagnosis and therapy of acute fatty liver in pregnancy are highlighted for the clinical routine based on case descriptions from three university hospitals, and reference is made to possible findings that are helpful in establishing the diagnosis. The angiogenic preeclampsia marker sFlt-1 plays a role and provides new opportunities to consider pathophysiological approaches.

Schlüsselwörter

Akute Schwangerschaftsfettleber (AFLP) - Schwangerschaftsspezifische Lebererkrankungen - Swansea-Kriterien - Unspezifisches Krankheitsgefühl in der Schwangerschaft

Key words

acute fatty liver of pregnancy (AFLP) - pregnancy-specific liver diseases - Swansea criteria - nonspecific feeling of illness in pregnancy


Publication History

Received: 02 October 2022

Accepted after revision: 03 May 2023

Article published online:
25 July 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Allen AM, Kim WR, Larson JJ. et al. The Epidemiology of Liver Diseases Unique to Pregnancy in a US Community: A Population-Based Study. Clin Gastroenterol Hepatol 2016; 14: 287-294 e281-282
    CrossrefPubMedSearch in Google Scholar
  • 2 Naoum EE, Leffert LR, Chitilian HV. et al. Acute Fatty Liver of Pregnancy: Pathophysiology, Anesthetic Implications, and Obstetrical Management. Anesthesiology 2019; 130: 446-461
    CrossrefPubMedSearch in Google Scholar
  • 3 Rath W, Tsikouras P, Stelzl P. HELLP Syndrome or Acute Fatty Liver of Pregnancy: A Differential Diagnostic Challenge: Common Features and Differences. Geburtshilfe Frauenheilkd 2020; 80: 499-507
    Thieme ConnectPubMedSearch in Google Scholar
  • 4 Janati-Idrissi Y, Slama L, Taheri H. et al. Recurrent acute fatty liver of pregnancy: About a case and a review of the literature. Gynecol Obstet Fertil Senol 2022; 50: 620-623
    CrossrefPubMedSearch in Google Scholar
  • 5 Tyni T, Ekholm E, Pihko H. Pregnancy complications are frequent in long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Am J Obstet Gynecol 1998; 178: 603-608
    CrossrefPubMedSearch in Google Scholar
  • 6 Ibdah JA. Acute fatty liver of pregnancy: an update on pathogenesis and clinical implications. World J Gastroenterol 2006; 12: 7397-7404
    CrossrefPubMedSearch in Google Scholar
  • 7 Shekhawat PS, Matern D, Strauss AW. Fetal fatty acid oxidation disorders, their effect on maternal health and neonatal outcome: impact of expanded newborn screening on their diagnosis and management. Pediatr Res 2005; 57: 78R-86R
    CrossrefPubMedSearch in Google Scholar
  • 8 Hay JE. Liver disease in pregnancy. Hepatology 2008; 47: 1067-1076
    CrossrefPubMedSearch in Google Scholar
  • 9 Steingrub JS. Pregnancy-associated severe liver dysfunction. Crit Care Clin 2004; 20: 763-776
    CrossrefPubMedSearch in Google Scholar
  • 10 Natarajan SK, Thangaraj KR, Eapen CE. et al. Liver injury in acute fatty liver of pregnancy: possible link to placental mitochondrial dysfunction and oxidative stress. Hepatology 2010; 51: 191-200
    CrossrefPubMedSearch in Google Scholar
  • 11 Prasun P, LoPiccolo MK, Ginevic I. Long-Chain Hydroxyacyl-CoA Dehydrogenase Deficiency/Trifunctional Protein Deficiency. In: Adam MP, Everman DB, Mirzaa GM et al., Hrsg. GeneReviews((R)). Seattle (WA). 1993
    Search in Google Scholar
  • 12 Monga M, Katz AR. Acute fatty liver in the second trimester of pregnancy. Prim Care Update Ob Gyns 1998; 5: 191
    CrossrefPubMedSearch in Google Scholar
  • 13 Panther E, Blum HE. Liver diseases in pregnancy. Dtsch Med Wochenschr 2008; 133: 2283-2287
    Thieme ConnectPubMedSearch in Google Scholar
  • 14 Dashe JS, Ramin SM, Cunningham FG. The long-term consequences of thrombotic microangiopathy (thrombotic thrombocytopenic purpura and hemolytic uremic syndrome) in pregnancy. Obstet Gynecol 1998; 91: 662-668
    CrossrefPubMedSearch in Google Scholar
  • 15 Ch'ng CL, Morgan M, Hainsworth I. et al. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut 2002; 51: 876-880
    CrossrefPubMedSearch in Google Scholar
  • 16 Trottmann F, Raio L, Amylidi-Mohr S. et al. Soluble fms-like tyrosine kinase 1 (sFlt-1): A novel biochemical marker for acute fatty liver of pregnancy. Acta Obstet Gynecol Scand 2021; 100: 1876-1884
    CrossrefPubMedSearch in Google Scholar
  • 17 Stepan H, Hund M, Andraczek T. Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome. Hypertension 2020; 75: 918-926
    CrossrefPubMedSearch in Google Scholar
  • 18 Nelson DB, Yost NP, Cunningham FG. Acute fatty liver of pregnancy: clinical outcomes and expected duration of recovery. Am J Obstet Gynecol 2013; 209: e451-e457
    CrossrefPubMedSearch in Google Scholar
  • 19 Westbrook RH, Yeoman AD, Joshi D. et al. Outcomes of severe pregnancy-related liver disease: refining the role of transplantation. Am J Transplant 2010; 10: 2520-2526
    CrossrefPubMedSearch in Google Scholar
  • 20 Pecks U, Mand N, Kolben T. et al. SARS-CoV-2 Infection During Pregnancy – An Analysis of Clinical Data From Germany and Austria From the CRONOS Registry. Dtsch Arztebl Int 2022; 10.3238/arztebl.m2022.0266
    CrossrefPubMedSearch in Google Scholar
  • 21 Kleinwechter H, Groten T, Schafer-Graf U. et al. COVID-19 and pregnancy. Gynakologe 2021; 54: 357-365
    CrossrefPubMedSearch in Google Scholar
  • 22 García-Romero CS, Guzman C, Cervantes A. et al. Liver disease in pregnancy: Medical aspects and their implications for mother and child. Ann Hepatol 2019; 18: 553-562
    CrossrefPubMedSearch in Google Scholar
  • 23 Bergmann F. RW. The differential diagnosis of thrombocytopenia in pregnancy–an interdisciplinary challenge. Dtsch Arztebl Int 2015; 112: 795-802
    CrossrefPubMedSearch in Google Scholar
  • 24 Rath W. Das HELLP-Syndrom – eine interdisziplinäre Herausforderung. Dtsch Arztebl International. 1998; 95 A-2997
    PubMedSearch in Google Scholar
  • 25 Abou-Dakn M. Microangiopathy during pregnancy: HELLP/aHUS/TTP taking COVID-19 in pregnancy into account. 2022
    PubMed
  • 26 Mjahed K, Charra B, Hamoudi D. et al. Acute fatty liver of pregnancy. Arch Gynecol Obstet 2006; 274: 349-353
    CrossrefPubMedSearch in Google Scholar
  • 27 Liu J, Ghaziani TT, Wolf JL. Acute Fatty Liver Disease of Pregnancy: Updates in Pathogenesis, Diagnosis, and Management. Am J Gastroenterol 2017; 112: 838-846
    CrossrefPubMedSearch in Google Scholar
  • 28 Pecks U, Rath W, Kleine-Eggebrecht N. et al. Maternal Serum Lipid, Estradiol, and Progesterone Levels in Pregnancy, and the Impact of Placental and Hepatic Pathologies. Geburtshilfe Frauenheilkd 2016; 76: 799-808
    Thieme ConnectPubMedSearch in Google Scholar
  • 29 Contini C, Winkler BS, Maass N. et al. Concomitant intrauterine growth restriction alters the lipoprotein profile in preeclampsia. Pregnancy Hypertens 2019; 15: 154-160
    CrossrefPubMedSearch in Google Scholar
  • 30 Contini C, Jansen M, Konig B. et al. Lipoprotein turnover and possible remnant accumulation in preeclampsia: insights from the Freiburg Preeclampsia H.E.L.P.-apheresis study. Lipids Health Dis 2018; 17: 49
    CrossrefPubMedSearch in Google Scholar
  • 31 Wetzka B, Hoffmann MM, Friedrich I. et al. Transient remnant removal disease in acute fatty liver of pregnancy. Hypertens Pregnancy 2004; 23: 143-153
    CrossrefPubMedSearch in Google Scholar